Re: TD Zenith Capital Corp | Grey Market : ZHCLF
in response to
by
posted on
Aug 18, 2020 04:32PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
From TD waterhouse Zenith Corp value now showing $2.04USd,